ReviewCurrent rheumatology reports2007
Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis.
Review in Current rheumatology reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.Journal of endocrinological investigation · 2009Trial
- Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway.Journal of molecular histology · 2021Article
- Autophagy as a target for glucocorticoid-induced osteoporosis therapy.Cellular and molecular life sciences : CMLS · 2018Review
- Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis.BioMed research international · 2018Article
- Glucocorticoid-induced osteoporosis: who to treat with what agent?Nature reviews. Rheumatology · 2015Review
- Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?The Korean journal of internal medicine · 2014Article
- Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study.Journal of endocrinological investigation · 2013Article
- A reappraisal of generic bisphosphonates in osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012Review
- A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology.Open access rheumatology : research and reviews · 2012Review
- An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011Article
- Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Therapeutics and clinical risk management · 2010Article
- Osteoporosis-related simultaneous four joints fractures and dislocation after a seizure: a case report.Journal of osteoporosis · 2010Article
- Management of glucocorticoid-induced osteoporosis.Nature reviews. Rheumatology · 2010Review
- Treatment of glucocorticoid-induced osteoporsis.Therapeutic advances in musculoskeletal disease · 2009Article
- Strategies for minimizing corticosteroid toxicity: a review.Indian journal of pediatrics · 2008Review
- Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells.British journal of pharmacology · 2008Article
- The pathophysiology of osteoporotic hip fracture.McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glucocorticoid-induced osteoporosis is a common but still relatively neglected problem, with a low level of awareness among primary and secondary care physicians. Fractures appear early after initiation of treatment, and effective prophylaxis requires primary prevention in those at high risk of fracture. Bisphosphonates are the treatment of choice, and calcium and vitamin D supplements are also indicated in the majority of individuals. Organized care programs together with the use of evidence-based guidelines have the potential to improve significantly the management of this serious complication of glucocorticoid therapy.
Indexed as
Identifiers
17437672What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.